Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02163603
Recruitment Status : Not yet recruiting
First Posted : June 13, 2014
Last Update Posted : March 21, 2016
Sponsor:
Collaborators:
Tongji Hospital
Wuhan Union Hospital, China
Hunan Children's Hospital
Shenzhen Children's Hospital
Foshan Hospital of Traditional Chinese Medicine
Wuhan Women and Children's Medical Center
Information provided by (Responsible Party):
Hongwen Xu, Guangzhou Women and Children's Medical Center

Brief Summary:
Developmental dislocation of the hip is a common disease in children, and its incidence in China is about 9 ‰.The pathological changes of it is complex. The reluxation , subluxation and residual deformity and other complications are relatively common after treatment. The X-ray appears great acetabular index and wide medial gap , small central-edge angle. As there is no effective methods for treating such complications , investigators conducted this trial to find and prove optimal intervention time and treatment programs.

Condition or disease Intervention/treatment
Developmental Dislocation of the Hip Congenital Dislocation of Hip Residual Deformity Reduction Procedure: Pelvic osteotomy

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: A Multi-center Study on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip
Study Start Date : September 2014
Estimated Primary Completion Date : December 2024

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Pelvic osteotomy Procedure: Pelvic osteotomy



Primary Outcome Measures :
  1. Early treatment can achieve good results in the residual deformity after reduction in developmental dislocation of the hip [ Time Frame: 3 years ]
    Acetabular index of all ages were measured ,and the acetabular index of patients getting early treatment (pelvis osteotomy ) is normal in all ages according to "The measurements of normal acetabular index and Sharp acetabular angle in Chinese hips" publised on Chinese Journal of Orthopaedics in 2010.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Year to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The south of China
Criteria

Inclusion Criteria:

  • The inclusion criteria consists of patients with large acetabular index ,small central-edge angle after reduction in developmental dislocation of the hip

Exclusion Criteria:

  • Age >14 years
  • Patients are complicated with mental, neurological disorders (such as hypoxic-ischemic encephalopathy, epilepsy and dementia) or significant barriers to growth.
  • Patients are complicated with cerebral palsy, multiple joint contractures disease.
  • Children are complicated with dysfunction of liver and kidney , blood disorders, immune deficiency disease and ECG abnormalities.
  • Parents refused further treatment.
Layout table for additonal information
Responsible Party: Hongwen Xu, Guangzhou Women and Children's Medical Center
ClinicalTrials.gov Identifier: NCT02163603    
Other Study ID Numbers: GuangzhouWCMC
First Posted: June 13, 2014    Key Record Dates
Last Update Posted: March 21, 2016
Last Verified: March 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Joint Dislocations
Hip Dislocation
Hip Dislocation, Congenital
Congenital Abnormalities
Joint Diseases
Musculoskeletal Diseases
Wounds and Injuries
Hip Injuries
Musculoskeletal Abnormalities